Difference between revisions of "US PA Philadelphia Falk MJ"
From Bioblast
Line 14: | Line 14: | ||
|Status=O2k 2008 - | |Status=O2k 2008 - | ||
|MiPNetLab=Polyak E | |MiPNetLab=Polyak E | ||
|keyword=Respiratory chain disease | |keyword=Respiratory chain disease | ||
}} | }} | ||
Line 20: | Line 19: | ||
* ''We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents.'' [[Falk MJ]] | * ''We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents.'' [[Falk MJ]] | ||
== Participated at == | |||
* IOC47 |
Revision as of 15:56, 8 February 2013
- We use the O2k to study permeabilized human cells and permeabilized mouse tissues to assess integrated respiratory capacity in different genetic mutants and in response to specific pharmacologic agents. Falk MJ
Participated at
- IOC47